A 48-year-old woman from Mumbai presents with a 6-week history of vaginal bleeding and lower abdominal pain. Pelvic ultrasound reveals a 5 cm heterogeneous mass in the uterus with increased vascularity. Serum β-hCG (human chorionic gonadotropin) is 45,000 mIU/mL (normal <5 mIU/mL in non-pregnant women), and serum AFP (alpha-fetoprotein) is 320 ng/mL (normal <10 ng/mL). Urine pregnancy test is negative. What is the most likely diagnosis, and what is the clinical significance of the elevated tumor markers?

Explanation

## Clinical Presentation Analysis This patient presents with: - Uterine mass with abnormal bleeding - **Markedly elevated β-hCG** (45,000 mIU/mL — >1000× normal) - **Elevated AFP** (320 ng/mL) - **Negative urine pregnancy test** (rules out normal pregnancy) ## Uterine Choriocarcinoma: Diagnosis and Marker Significance **Key Point:** Uterine choriocarcinoma is a highly aggressive gestational trophoblastic neoplasia that produces β-hCG as its primary tumor marker. Elevated AFP indicates germ cell differentiation or coexisting teratomatous/embryonal elements. ### β-hCG in Choriocarcinoma | Feature | Details | |---------|----------| | **Source** | Syncytiotrophoblastic cells of the tumor | | **Sensitivity** | ~100% in choriocarcinoma; markedly elevated (often >10,000 mIU/mL) | | **Specificity** | High for trophoblastic disease when markedly elevated in non-pregnant women | | **Clinical use** | Diagnosis, prognostication, monitoring treatment response, detecting recurrence | | **Prognostic significance** | Higher β-hCG correlates with tumor burden and poor prognosis | **High-Yield:** In a non-pregnant woman with a uterine mass and markedly elevated β-hCG (>10,000 mIU/mL), choriocarcinoma is the diagnosis until proven otherwise. ### AFP Elevation in Choriocarcinoma - **Indicates germ cell differentiation** within the tumor - Suggests **coexisting teratomatous or embryonal elements** (mixed gestational trophoblastic tumor) - **Does NOT occur** in pure hydatidiform moles or typical choriocarcinoma without germ cell components - Presence of both β-hCG and AFP indicates a more aggressive, mixed histology **Clinical Pearl:** The combination of markedly elevated β-hCG + elevated AFP in a uterine mass strongly suggests a mixed gestational trophoblastic neoplasia with germ cell differentiation, requiring urgent chemotherapy (methotrexate, dactinomycin, or multiagent regimens). ## Diagnostic and Prognostic Approach ```mermaid flowchart TD A[Non-pregnant woman with uterine mass]:::outcome --> B{β-hCG level?}:::decision B -->|Markedly elevated >10,000| C[Gestational trophoblastic neoplasia]:::outcome C --> D{AFP also elevated?}:::decision D -->|Yes| E[Mixed GTN with germ cell differentiation]:::outcome D -->|No| F[Pure choriocarcinoma or mole]:::outcome E --> G[High-risk disease]:::urgent F --> H{Risk stratification}:::decision G --> I[Multiagent chemotherapy]:::action H -->|High-risk| J[Multiagent chemotherapy]:::action H -->|Low-risk| K[Single-agent methotrexate]:::action ``` **Mnemonic:** **CHORIO** — **C**ells produce **H**CG, **O**ften with **R**ising markers, **I**ndicating **O**ncologic emergency.